US 9663783
Modulation of alpha synuclein expression
granted A61PA61P21/00A61P25/00
Quick answer
US patent 9663783 (Modulation of alpha synuclein expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P21/00, A61P25/00, A61P25/02, A61P25/16